|
Ackroyd, R., C. Kelty, et al. (2001). The history of photodetection and photodynamic therapy. Photochem Photobiol 74(5): 656-69.Bermudez Moretti, M., S. Correa Garcia, et al. (1993). Delta-aminolevulinic acid transport in Saccharomyces cerevisiae.Int J Biochem 25(12): 1917-24.Berenbaum, M. C., S. L. Akande, et al. (1986). Meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumor photosensitisers with favourable selectivity. Br J Cancer 54(5): 717-25.Boukamp, P., R. T. Petrussevska, et al. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 10761-71.Bown, S. G., C. J. Tralau, et al. (1986). Photodynamic therapy with porphyrin and phthalocyanine sensitization: quantitative studies in normal rat liver. Br J Cancer 54(1): 43-52.Calzavara-Pinton, P. G. (1995). Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non - melanoma skin tumours. J Photochem Photobiol B 29(1): 53-7.Chevretton, E. B., M. C. Berenbaum and R. Bonnett. (1992). The effect of photodynamic therapy on normal skeletal muscle in an animal model. Lasers Med Sci 7: 103-110. Chiang, L. C., W. Chiang, et al. (1994). Establishment and characterization of a continuous human basal cell carcinoma cell line from facial skin (I) cytological behavior of early passages. Kaohsiung J Med Sci 10 (4): 170-6.De Rosa, F. S. and M. V. Bentley (2000). Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm Res 17(12): 1447-55.Divaris, D. X., J. C. Kennedy, et al. (1990). Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 136(4): 891-7.Doring, F., J. Walter, et al. (1998). Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Invest 101(12): 2761-7.Elliott, T. (1993). Transport of 5-aminolevulinic acid by the dipeptide permease in Salmonella typhimurium. J Bacteriol 175(2): 325-31.Elfsson, B., I. Wallin, S. Eksborg, et al. (1998). Stability of 5-aminolevulinic acid in aqueous solution. Eur J Pharm Sci 7: 87-91.Fink-Puches, R., H. P. Soyer, et al. (1998). Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 134(7): 821-6.Fromm, D., D. Kessel, et al. (1996). Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch Surg 131(6): 667-9.Fuchs, C., R. Riesenberg, et al. (1997). pH-dependent formation of 5-aminolaevulinic acid-induced protoporphyrin IX in fibrosarcoma cells. J Photochem Photobiol B 40(1): 49-54.Gibson, S. L., D. J. Cupriks, et al. (1998). A regulatory role for porphobilinogen deaminase (PBGD) in delta- aminolaevulinic acid (delta-ALA)-induced photosensitization. Br J Cancer 77(2): 235-43.Haller, J. C., F. Cairnduff, et al. (2000). Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143(6): 1270-5.Hansen, M. B., S. E. Nielsen, et al. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119(2): 203-10.Heinritz, H., W. Benzel, et al. (1995). Photodynamic therapy of superficial skin tumors following local application of delta-aminolaevulinic acid. Adv Otorhinolaryngol 49: 48-52.Kalka, K., H. Merk, et al. (2000). Photodynamic therapy in dermatology. J Am Acad Dermatol 42(3): 389-413.Kennedy, J. C., R. H. Pottier, et al. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6(1-2): 143-8.Kessel, D., M. Antolovich, et al. (2001). The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. Photochem Photobiol 74(2): 346-9.Kondo, M., N. Hirota, et al. (1993). Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9(1): 95-105.Lui, H. and R. R. Anderson (1992). Photodynamic therapy in dermatology. Shedding a different light on skin disease. Arch Dermatol 128(12): 1631-6.Martin, A., W. D. Tope, et al. (1995). Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 287(7): 665-74.Mesenholler, M. and E. K. Matthews (2000). A key role for the mitochondrial benzodiazepine receptor in cellular photosensitisation with delta-aminolaevulinic acid. Eur J Pharmacol 406(2): 171-80.Moan, J., O. Bech, et al. (1998). Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle. Int J Cancer 75(1): 134-9.Morton, C. A., S. B. Brown, et al. (2002). Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4): 552-67.Peng, Q., A. M. Soler, et al. (2001). Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 62(3): 140-5.Peng, Q., T. Warloe, et al. (1995). Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62(5): 906-13.Peng, Q., T. Warloe, et al. (1997). 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79(12): 2282-308.Peng, Q., K. Berg, et al. (1997). 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65(2): 235-51.Pope, A. J. and S. G. Bown (1991). The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. J Urol 145(5): 1064-70.Pottier, et al. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6(1-2): 143-8.Rud, E., O. Gederaas, et al. (2000). 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 71(5): 640-7.Riesenberg, R., C. Fuchs, et al. (1996). Photodynamic effects of 5-aminolevulinic acid-induced porphyrin on human bladder carcinoma cells in vitro. Eur J Cancer 32A(2): 328-34.Santoro, O., G. Bandieramonte, et al. (1990). Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinoma. Cancer Res 50(15): 4501-3.Soler, A. M., T. Warloe, et al. (2001). A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145(3): 467-71.Szeimies, R. M., P. Calzavara-Pinton, et al. (1996). Topical photodynamic therapy in dermatology. J Photochem Photobiol B 36(2): 213-9.Tsai, J. C., I. H. Chen, et al. (2002). In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation. Br J Dermatol 146(5): 853-62.Uberriegler, K. P., E. Banieghbal, et al. (1995). Subcellular damage kinetics within co-cultivated WI38 and VA13-transformed WI38 human fibroblasts following 5-aminolevulinic acid-induced protoporphyrin IX formation. Photochem Photobiol 62(6): 1052-7.Verkamp, E., V. M. Backman, et al. (1993). The periplasmic dipeptide permease system transports 5-aminolevulinic acid in Escherichia coli. J Bacteriol 175(5): 1452-6.Warloe, T., H. Heyerdahl, Q. Peng, et al. (1994). Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma. SPIE 2371 :226-235Wolf, P. and H. Kerl (1995). Photodynamic therapy with 5-aminolevulinic acid: a promising concept for the treatment of cutaneous tumors. Dermatology 190(3): 183-5.
|